Epidermal growth factor receptor exon 19 deletions predict complete regression of multiple intracranial metastases in two cases of non-small cell lung cancer treated with erlotinib

J Thorac Oncol. 2009 Jul;4(7):936-7. doi: 10.1097/JTO.0b013e3181a9a0a2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Brain Neoplasms / secondary*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Diagnosis, Differential
  • ErbB Receptors / genetics*
  • Erlotinib Hydrochloride
  • Exons
  • Fatal Outcome
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology*
  • Male
  • Middle Aged
  • Mutation
  • Protein Kinase Inhibitors
  • Quinazolines / therapeutic use*
  • Tomography, X-Ray Computed

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors